News

January 2007

Novel Treatments for Obesity and Type 2 Diabetes -

John Baxter, MD and Paul Webb, PhD are focused on studying the thyroid hormone which regulates overall metabolic rate, heart function and cholesterol and triglyceride levels.

Demand for First Fellowships Awarded by California Institute for Regenerative Medicine Is Huge -

CIRM, the voter-established institute created by Prop 71, awarded $12.

June 2006

Justine K. Schreyer Endowed Chair in Diabetes Research -

Dr. Michael German has been appointed to this new chair, which was generously funded through donations from long-time UCSF volunteer leader, Chara Schreyer and her Kadima Foundation.

UCSF Tolerance Research Featured in JDRF's Countdown Magazine

Important Research Finding in Type 1 Research -

April's issue of Journal of Clinical Investigation reported that UCSF’s Dr. Jeffrey Bluestone and his collaborators Matthias von Herrath and Damien Bresson at the La Jolla Institute for Allergy and Immunology and Kevan Herold of Columbia University have successfully used a new treatment approach to reverse recent onset type 1 diabetes in laboratory animals.

May 2006

Dr. Bluestone Named to the American Academy of Arts & Sciences -

Two UCSF faculty scientists have been elected to the American Academy of Arts and Sciences, the academy announced on April 24, 2006.

April 2006

Are We Destined to Gain Weight? -

Christian Vaisse, MD, PhD, studies weighty matters - the genetics of obesity.

December 2005

Scientists Directly View Immune Cells Interacting to Avert Autoimmunity -

Using a new form of microscopy to penetrate living lymph nodes, UCSF scientists have for the first time viewed immune cells at work, helping clarify how T cells control autoimmunity.

August 2005

Where is the Cure? -

An editorial by Dr. Stephen Gitelman: I am often asked the question, “Where is the cure for diabetes?” As a pediatrician, I think the ultimate cure for diabetes will be prevention. Why can’t we prevent someone from getting diabetes in the first place? To answer that, we need to first determine if we can predict who is going to get type 1 diabetes.

Diabetes Center's Matthias Hebrok to Lead International Beta Cell Regeneration Team -

Diabetes Center researcher and stem cell expert Dr. Matthias Hebrok, PhD has been picked to help lead an international “dream team” of researchers that will search for ways of coaxing beta cells to regenerate themselves.